Preventing Harm from High-Alert Medications

被引:32
作者
Federico, Frank [1 ]
机构
[1] Inst Healthcare Improvement, Mill Lives Campaign 5, Cambridge, MA 02138 USA
关键词
D O I
10.1016/S1553-7250(07)33057-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: One of the 12 interventions that the Institute for Healthcare Improvement (IHI) recommends for its 5 Million Lives Campaign is "Prevent Harm from High-Alert Medications ... starting with a focus on anticoagulants, sedatives, narcotics, and insulin." Executing System-Level Changes: Three essential elements are needed to execute system-level changes in an organization: will, ideas, and execution. Will is developed by examining the status quo in an organization and agreeing that it is no longer acceptable. Ideas-changes that will make the system safer-can be found in the literature and in the experience of other hospitals and are the basis for the recommended general interventions to reduce errors and harm associated with high-alert medications. Execution, the process of making those changes real, requires commitment from senior leaders and clinical leaders, along with the organizational capacity to improve. The steps in the medication system are so interrelated that a change in one area will affect others' ability to complete their work. In addition, senior leadership and clinical leadership must visibly support the effort, connecting the reduction in high-alert medication-related harm to the overall hospital goal of harm reduction is essential. Conclusion: The campaign's goal is to achieve a 50% reduction in harm related to high-alert medications. Employing strategies such as standardization and simplification will provide the foundation for improved medication safety.
引用
收藏
页码:537 / 542
页数:6
相关论文
共 20 条
[1]  
[Anonymous], ISMPS LIST HIGH AL M
[2]   RELATIONSHIP BETWEEN MEDICATION ERRORS AND ADVERSE DRUG EVENTS [J].
BATES, DW ;
BOYLE, DL ;
VLIET, MVV ;
SCHNEIDER, J ;
LEAPE, L .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1995, 10 (04) :199-205
[3]   National surveillance of emergency department visits for outpatient adverse drug events [J].
Budnitz, Daniel S. ;
Pollock, Daniel A. ;
Weidenbach, Kelly N. ;
Mendelsohn, Aaron B. ;
Schroeder, Thomas J. ;
Annest, Joseph L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (15) :1858-1866
[4]   Improving medication safety: the measurement conundrum and where to start [J].
Classen, DC ;
Metzger, J .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2003, 15 :I41-I47
[5]  
Griffin F., 2007, IHI INNOVATION SERIE
[6]  
Institue for Safe Medication Practices (ISMP), 2003, ISMP MED SAF AL AC C
[7]  
Institute for Safe Medication Practices (ISMP), ISMP SELF ASS
[8]  
Institute of Medicine (IOM), 2006, PREVENTING MEDICATIO
[9]   Nature of preventable adverse drug events in hospitals: A literature review [J].
Kanjanarat, P ;
Winterstein, AG ;
Johns, TE ;
Hatton, RC ;
Gonzalez-Rothi, R ;
Segal, R .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (17) :1750-1759
[10]   THE NATURE OF ADVERSE EVENTS IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-II [J].
LEAPE, LL ;
BRENNAN, TA ;
LAIRD, N ;
LAWTHERS, AG ;
LOCALIO, AR ;
BARNES, BA ;
HEBERT, L ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :377-384